Earli
Moataz Reda is an experienced professional in the field of biomedical engineering, currently serving as an Associate Principal Scientist at Earli Inc. since December 2024. Prior to this role, Moataz held various positions at PDX Pharmaceuticals from July 2019 to December 2024, advancing from Scientist to Principal Scientist. Beginning a career in research, Moataz worked as a Research Assistant at Washington State University from December 2010 to May 2013 and at Oregon Health and Science University as a Research Assistant II in 2014. Moataz earned a PhD in Biomedical Engineering from Oregon Health & Science University in 2019, following a Bachelor's degree in Bioengineering from Washington State University in 2013.
This person is not in any teams
Earli
1 followers
Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.